Waszkowycz; Bohdan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Waszkowycz; Bohdan.The latest application filed is for "parg inhibitory compounds".
Company Profile
8.23.22
- Waszkowycz; Bohdan - Manchester GB
- Waszkowycz; Bohdan - Harlow N/A GB
- Waszkowycz; Bohdan - Slough N/A GB
- Waszkowycz; Bohdan - Macclesfield GB
- Waszkowycz; Bohdan - Berkshire GB
- Waszkowycz; Bohdan - Harlow Essex GB
- Waszkowycz; Bohdan - Wilmslow GB
- Waszkowycz, Bohdan - Cheshire GB
Patent Activity
| Patent | Date |
|---|---|
| Compounds useful as RET inhibitors Grant 11,352,361 - Jordan , et al. June 7, 2 | 2022-06-07 |
| Parg Inhibitory Compounds App 20210380539 - MCGONAGLE; Alison E. ; et al. | 2021-12-09 |
| Heterocyclic Compounds as RET Kinase Inhibitors App 20210155628 - Jordan; Allan Michael ; et al. | 2021-05-27 |
| Substituted pyridines as inhibitors of DNMT1 Grant 10,975,056 - Adams , et al. April 13, 2 | 2021-04-13 |
| Heterocyclic compounds as ret kinase inhibitors Grant 10,954,241 - Jordan , et al. March 23, 2 | 2021-03-23 |
| Heterocyclic Compounds as RET Kinase Inhibitors App 20210047334 - Jordan; Allan Michael ; et al. | 2021-02-18 |
| Heterocyclic compounds as RET kinase inhibitors Grant 10,844,067 - Jordan , et al. November 24, 2 | 2020-11-24 |
| Compounds Useful as RET Inhibitors App 20200157107 - Jordan; Allan ; et al. | 2020-05-21 |
| PARG inhibitory compounds Grant 10,508,086 - McGonagle , et al. Dec | 2019-12-17 |
| Heterocyclic Compounds As Ret Kinase Inhibitors App 20190263819 - Jordan; Allan ; et al. | 2019-08-29 |
| Heterocyclic Compounds As Ret Kinase Inhibitors App 20190106425 - Jordan; Allan ; et al. | 2019-04-11 |
| 2,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG Grant 10,239,843 - McGonagle , et al. | 2019-03-26 |
| Parg Inhibitory Compounds App 20180194738 - MCGONAGLE; Alison E. ; et al. | 2018-07-12 |
| 2,4-dioxo-quinazoline-6-sulfonamide Derivatives As Inhibitors Of Parg App 20180016242 - MCGONAGLE; Alison E. ; et al. | 2018-01-18 |
| Benzoxazepin compounds selective for PI3K P110 delta and methods of use Grant 9,090,628 - Heffron , et al. July 28, 2 | 2015-07-28 |
| Heterocyclic compounds and methods of use Grant 8,653,089 - Heald , et al. February 18, 2 | 2014-02-18 |
| Triazolopyridine derivatives and their therapeutic use Grant 8,557,797 - Finch , et al. October 15, 2 | 2013-10-15 |
| Tricyclic heterocyclic compounds, compositions and methods of use thereof Grant 8,461,328 - Babu , et al. June 11, 2 | 2013-06-11 |
| Pyrimidopyridazine derivatives useful as P38 MAPK inhibitors Grant 8,450,314 - Beswick , et al. May 28, 2 | 2013-05-28 |
| Organic Compounds App 20130012485 - Baschlin; Daniel Kaspar ; et al. | 2013-01-10 |
| Heterocyclic Compounds And Methods Of Use App 20120202785 - Heald; Robert ; et al. | 2012-08-09 |
| Triazolopyridine Derivatives And Their Therapeutic Use App 20120088763 - Finch; Harry ; et al. | 2012-04-12 |
| Pyrimidopyridazine Derivatives Useful As P38 Mapk Inhibitors App 20120077809 - Beswick; Amanda ; et al. | 2012-03-29 |
| Tricyclic Heterocyclic Compounds, Compositions And Methods Of Use Thereof App 20110201593 - Babu; Srinivasan ; et al. | 2011-08-18 |
| Meta-benzamidine derivatives as serine protease inhibitors Grant 7,928,137 - Liebeschuetz , et al. April 19, 2 | 2011-04-19 |
| Serine protease inhibitors Grant 7,381,734 - Lively , et al. June 3, 2 | 2008-06-03 |
| Meta-benzamidine derivatives as serine protease inhibitors App 20070155790 - Liebeschuetz; John Walter ; et al. | 2007-07-05 |
| Meta-benzamidine derivatives as serine protease inhibitors Grant 7,220,781 - Liebeschuetz , et al. May 22, 2 | 2007-05-22 |
| Serine protease inhibitors Grant 7,157,585 - Lively , et al. January 2, 2 | 2007-01-02 |
| Serine protease inhibitors Grant 7,074,934 - Lively , et al. July 11, 2 | 2006-07-11 |
| Serine protease inhibitors Grant 7,067,516 - Lively , et al. June 27, 2 | 2006-06-27 |
| Serine protease inhibitors App 20050267173 - Lively, Sarah Elizabeth ; et al. | 2005-12-01 |
| Serine protease inhibitors App 20050215587 - Lively, Sarah Elizabeth ; et al. | 2005-09-29 |
| Serine protease inhibitors Grant 6,916,957 - Lively , et al. July 12, 2 | 2005-07-12 |
| Meta-benzamidine derivatives as serine protease inhibitors App 20040143018 - Liebeschuetz, John Walter ; et al. | 2004-07-22 |
| Serine protease inhibitors App 20040116439 - Lively, Sarah Elizabeth ; et al. | 2004-06-17 |
| Serine protease inhibitors App 20030216403 - Lively, Sarah Elizabeth ; et al. | 2003-11-20 |
| Serine protease inhibitors App 20030018059 - Lively, Sarah Elizabeth ; et al. | 2003-01-23 |
| Meta-benzamidine derivatives as serine protease inhibitors App 20020055522 - Liebeschuetz, John Walter ; et al. | 2002-05-09 |
| 1-amino-7-isoquinoline derivatives as serine protease inhibitors App 20020040144 - Liebeschuetz, John Walter ; et al. | 2002-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 